| Tag | Content |
|---|
EnhancerAtlas ID | HS020-03503 |
Organism | Homo sapiens |
Tissue/cell | CD34+ |
Coordinate | chr1:183589620-183591970 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEF2C | MA0497.1 | chr1:183589893-183589908 | TTCTATTTTTAAATT | - | 6.5 | | NFAT5 | MA0606.1 | chr1:183591372-183591382 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr1:183591372-183591382 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr1:183591372-183591382 | AATGGAAAAT | - | 6.02 | | Nr5a2 | MA0505.1 | chr1:183590658-183590673 | GAATTCAAGGCCAGT | + | 6.41 | | SPI1 | MA0080.4 | chr1:183591352-183591366 | CAAAAGAGGAACTA | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_65086 | chr1:183588357-183590217 | NHEK | | SE_65086 | chr1:183591438-183592877 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr1 | 183590559 | 183591124 | | chr1 | 183591501 | 183591559 | | chr1 | 183591835 | 183591875 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH01I183619 | chr1 | 183588358 | 183590217 | | GH01I183622 | chr1 | 183591536 | 183592865 |
|
Enhancer Sequence | CAGCCCTTAG CATGTAAATA CTTGCCTGAA TGACAGTGAA ACTGTGCTTT CACGTGCGAA 60
ATACTTTGGG TAGTTTGTCT TAAGAAAACA CCCTCAAGTC CTGAGAAAAC CAACCAAGTC 120
AATATATTAG GATAAGACTT CCATATGGGG ACCAACTAAT CTCTTCTAGT TTACATTTGA 180
AGCAGCAATT GTTGAAAAGA AAAATATGAA TATTTTAAAA TAAAAAAACT AAAATTTAAA 240
ATCATAAAAA CATCCAAGAA CACTTCATGA AATTTCTATT TTTAAATTTT GGAGCCAGGA 300
AAATCTAAGT ATGACTTGAA CTCTAAATGC CATAAGAAAA GATTAATAAA CTCAATTAGA 360
TAAAAATAAA AATAACCTTT TTATTTATAG TAAAAGCTAT TATAAAGCGA AACTCAAAAT 420
GCAAGAAATA TTTGACATTC CTGTTGAAAA GAGCTCCTAC AAATCAGTAA GAAAAAGACC 480
ATCAAAAGGG CAAAGAAAAT ATAGAAATAC AAAAATATAG AAAAGAAAAT ACAACTGGCT 540
ATTAGGCATG TGAAAAGATG TGCAATCTCA TTTACATTAA GAGAAATGCA AATATATGAT 600
ACCATTTTTA AAACATCAGA TTTGAAAAGA TTAAAAAATG TTTTATGACA AACACATAGA 660
ATAGGTAAAG GGGTGGGAAA ACATGCATTC TTCTACACGG CTGGAGAAAG TATAATTGAT 720
AAAACCTTTA AGAAAGGCAA TTTAGCAATA TCTCCCTTAA ATGCCCTCCA ACTGACCTTA 780
ACTTTCACTT TTAGGAATTG ATCTACAAAT AGGCTTGAAC ATATGTAAAA TGACTTGTGT 840
ATAATGCTAT TCACTGTAGC ACTGTTTGTA ACTGCAAAAG ATCAGAAACC ACCTAAATCA 900
ATAGGGAAAT GGTTAAGTAA ATTATGGTAC ATTTATTTAT ATAATAGAAT TATTATGCAG 960
TCATAAAAAT AAAATTGTTA TCGGAAAGTG GTCCCAATCC AGACCCCAAG TGAGCGTTCT 1020
TGGATCTCAC ACAAGAAAGA ATTCAAGGCC AGTCTGTAAA GTTAAAGCAA GTTTATTAAG 1080
AAAGTAAAGG AATAAAGAAT GGCTACTCCA TAGGCAGAGC AGCCCCGAGG GCTGCTGGTT 1140
GCCCATTTTA ACGGTTATTT CTTGATGATA TGCTAAACAA GGGGTGTATT ATTCATGCCT 1200
CCCCTTTTTA GACCATATAG GATAACTTCC TGATGTTGCC ATGGCATTTG TAAACTGTCA 1260
TGGTGCCGGT GGGAGCGTAG CGGTGAGGAT GGCCAGAGGC AGAGGTCACT TTCATTGCCA 1320
TCTTGGATTT GGTGGGTTTT GGCCAGCTTC TTTACTGCAA ACTGTTTTAT CAGCAAGGTC 1380
TTTATGACCG GTATCTTGTG TTGACCTCCT ATCTCATCCT GTGACTTAGA ATGCCTTAAC 1440
CATCTGGGAA TGCAGCCCAG TAGGTCTCAG CCTTATTTTA CCCAGCTTCT ATTCAAGAAG 1500
GAATTGCTCT GGTTCAAATG CCTCTGAAGG GAATAAGGAA GTTCTTTATG TATTGATAGG 1560
AAATTACCAC CAAAATATAC TGTTAATGAA AAAAGCAAGG AACAGAACAC TATATATAGT 1620
ATGTTAGTAT TTATGTACAC AAAGGGGTAA AATCTTATAT AGGTATTTGC CTGTAAATGC 1680
ATACACTGTA TCTGGAAGGA TGCCTAAGAA TTAAGTGACA ATAGTTGGTT GTCAAAAGAG 1740
GAACTAGGGT GGAATGGAAA ATTACCACAG TACATATTTC TTACCTTTTG AATATTGAAC 1800
AATATGAACA AATTATTTGA AAACGAATAA AAACTAAAAT GAATAAAATA CAGAACCATT 1860
GGCTAATGAA TACACTGACC TTTAACTTAG CAAATTGAAG AAAATCTTAG TTGCCCTGGC 1920
ATCTTGATTC AATTTTTGGA GAAACAAAAG GAAGTATGAT GTTATTCAGA GGCATTGGCC 1980
ATTTAAGTTA TTCATTACCC TAAGGGTTGA CAGAATTAGA AAAATCTACG TATAAAGTCA 2040
AGGACGGTGA TATAAATTCA TGGATATAAT TTAATGGTTA TCTTTAAGGA AAACAAGGGG 2100
TATTGGGTCA CATCTCTGCT CTTAGAAGGT GATGCCACAG AATAATGAAC AGATCATATA 2160
AACTCCCATA GTGCCACTGT TAGCCAGATA TGAGCTGGAA TTCTGTTCCT CAGCCACTTT 2220
CTCTGGTGAC TTCTGGCAAA GCTAAACACT ATAGGGGCTG CACGTGGTAC TCATGGTGGC 2280
TCTGATTTCC ACCTAAGGCT GATAAATTCC CTTCTTAACT GTCCACATTG AAGTGAATTG 2340
AAATTCTTTG 2350
|
